AMRS, NVTA & Other Top Stocks for the Week Happy Sunday everyone and welcome to Money Talk Sundayz. If you’re tuning in via spotify, anchor, or from any of the popular podcast streaming platforms I’m your host Stevie Bee. Go ahead and drop a like on your way in the door. Let’s rap money. The market wrapped up another positive week in trading reaffirming the notion that we are out of the woods and that THE BEST IS YET TO COME!!! Let’s talk about some of the winners of this past week. At the top of the list with the biggest gains for the week is Invitae Corporation (NVTA). The day after the earnings release, the stock shot up 276%, landing at a previously unimaginable $8.63 a share. The CEO's comments on "improvements in several key metrics" were duly noted, but a share-price move of this magnitude is difficult to justify by the data alone. It sits comfortably this Sunday morning at 5.37. According to Stock Analysis NVTA had a positive change of over 125% for the week. Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. Following NVTA we have Aquestive Therapeutics, Inc. (Nasdaq: AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives. This stock has seen over 110% positive growth this week closing out the week at 1.73. In after-market it has increased it a little bit more to 1.86. I’m not too familiar with this stock so let’s see what the net says. Aquestive Therapeutics Inc (AQST) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AQST received an overall rating of 64, which means that it scores higher than 64 percent of all stocks. Aquestive Therapeutics Inc also achieved a score of 87 in the Drug Manufacturers - Specialty & Generic industry, putting it above 87 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 138 out of the 148 industries. Word is investors in this stock from last year are still down 68% in spite of the 40% gains this past week. Knowing that, it’s as good a time as any to go ahead and build your position in this stock if this company interests you. Personally, I’m considering opening a position in this stock to swing short term. Catch the upward bounce you feel me. Rounding out the top 5 in third place we have Twin Vee PowerCats Co. ticker symbol VEEE. In fourth place, Verona Pharma PLC symbol VRNA. In 5th place we have Amyris Inc ticker symbol AMRS. All three had a positive change in the 90th percentile. Do any of these stocks interest you? Did you make money on any of them this week? Let me know in the comments section. Happy Sunday and have a profitable week bros nation.